Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Long-Term Debt Issuances (2010 - 2020)

Omeros (OMER) posted Long-Term Debt Issuances of $225.0 million for Q3 2020, up 157.06% sequentially from $87.5 million in Q4 2018.

Analysis

Omeros (OMER) Long-Term Debt Issuances (2010 - 2020) Analysis & Trends

Omeros has reported Long-Term Debt Issuances for 9 years, with the latest figure at $225.0 million in Q3 2020.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $225.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $312.5 million (changed N/A YoY) and the FY2020 annual result came in at $225.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances rose to $225.0 million in Q3 2020 per OMER's latest filing, from $87.5 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $225.0 million in Q3 2020 and troughed at -$19.8 million in Q3 2016.
  • A 4-year average of $58.9 million and a median of $19.9 million in 2016 frame the typical range for Long-Term Debt Issuances.
  • The sharpest annual moves came in 2016 and 2017: Long-Term Debt Issuances surged 99.88% in 2016, then plunged 100.26% in 2017.
  • Over 4 years, Long-Term Debt Issuances stood at $99.9 million in 2016, then slumped by 100.05% to -$51000.0 in 2017, then surged by 171721.57% to $87.5 million in 2018, then surged by 157.06% to $225.0 million in 2020.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $225.0 million, $87.5 million, and -$51000.0 for Q3 2020, Q4 2018, and Q2 2017 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 225.00 Mn
Dec 31, 2018 165.45 Mn
Jun 30, 2017 -51,000.00
Mar 31, 2017 51,000.00
Dec 31, 2016 80.14 Mn
Jun 30, 2016 19.86 Mn
Dec 31, 2015 248,000.00
Sep 30, 2015 2.40 Mn
Jun 30, 2015 2.34 Mn
Dec 31, 2014 19.30 Mn
Mar 31, 2014 12.70 Mn
Dec 31, 2012 1.90 Mn
Sep 30, 2012 1.57 Mn
Jun 30, 2012 1.53 Mn
Mar 31, 2012 1.50 Mn
Mar 31, 2011 9.94 Mn
Dec 31, 2010 8.88 Mn
Sep 30, 2010 1.42 Mn